Ocular drug delivery: present innovations and future challenges

V Gote, S Sikder, J Sicotte, D Pal - Journal of Pharmacology and …, 2019 - ASPET
Ocular drug delivery has always been a challenge for ophthalmologists and drug-delivery
scientists due to the presence of various anatomic and physiologic barriers. Inimitable static …

Phytochemistry, pharmacological activity, and potential health benefits of Glycyrrhiza glabra

MK Hasan, I Ara, MSA Mondal, Y Kabir - Heliyon, 2021 - cell.com
Nature has always been an excellent source for many therapeutic compounds providing us
with many medicinal plants and microorganisms producing beneficial chemicals. Therefore …

Polymeric micelles for ocular drug delivery: From structural frameworks to recent preclinical studies

A Mandal, R Bisht, ID Rupenthal, AK Mitra - Journal of Controlled Release, 2017 - Elsevier
Effective intraocular drug delivery poses a major challenge due to the presence of various
elimination mechanisms and physiological barriers that result in low ocular bioavailability …

Self-implantable double-layered micro-drug-reservoirs for efficient and controlled ocular drug delivery

A Than, C Liu, H Chang, PK Duong… - Nature …, 2018 - nature.com
Eye diseases and injuries impose a significant clinical problem worldwide. Safe and
effective ocular drug delivery is, however, challenging due to the presence of ocular barriers …

BCLA CLEAR-Contact lens complications

F Stapleton, M Bakkar, N Carnt, R Chalmers… - Contact Lens and …, 2021 - Elsevier
Contact lens-related complications are common, affecting around one third of wearers,
although most are mild and easily managed. Contact lenses have well-defined anatomical …

Vascular endothelial growth factor signaling in hypoxia and inflammation

S Ramakrishnan, V Anand, S Roy - Journal of neuroimmune …, 2014 - Springer
Infection, cancer and cardiovascular diseases are the major causes for morbidity and
mortality in the United States according to the Center for Disease Control. The underlying …

Clinical pharmacology of intravitreal anti-VEGF drugs

S Fogli, M Del Re, E Rofi, C Posarelli, M Figus… - Eye, 2018 - nature.com
Clinical efficacy of intravitreal anti-VEGF drugs has been widely demonstrated in several
angiogenesis-driven eye diseases including diabetic macular edema and the neovascular …

Ocular delivery of proteins and peptides: Challenges and novel formulation approaches

A Mandal, D Pal, V Agrahari, HM Trinh… - Advanced drug delivery …, 2018 - Elsevier
The impact of proteins and peptides on the treatment of various conditions including ocular
diseases over the past few decades has been advanced by substantial breakthroughs in …

Therapeutic potentials of gene silencing by RNA interference: principles, challenges, and new strategies

Y Deng, CC Wang, KW Choy, Q Du, J Chen, Q Wang… - Gene, 2014 - Elsevier
During recent decades there have been remarkable advances in biology, in which one of
the most important discoveries is RNA interference (RNAi). RNAi is a specific post …

Biodegradable silicon nanoneedles for ocular drug delivery

W Park, VP Nguyen, Y Jeon, B Kim, Y Li, J Yi, H Kim… - Science …, 2022 - science.org
Ocular drug delivery remains a grand challenge due to the complex structure of the eye.
Here, we introduce a unique platform of ocular drug delivery through the integration of …